Manchester Medical Society

Events & Meetings

Become a member

Nuclear Neuroradiology: the expanding role of Nuclear Medicine and PET CT in Neurology and Neurosurgery patients

Dr John Cain

  • Date: Wednesday 21st November 2018 from 6.00 pm
  • Venue: Education Centre, Royal Albert Edward Infirmary, Wigan Lane, Wigan, WN1 2NN
  • Members £0.00
  • Non Members FREE
Book this event

Directions to Royal Albert Edward Infirmary

6.00 pm    Dr Choong Poon to introduce & welcome to Wigan meeting
6.05 pm    Mr Andrew Bradley, President, Section of Imaging Manchester Medical Society
6.10 pm    Dr Susan Tebby-Lees, NW RCR Subcommittee
6.20 pm    Dr Roger Laitt, Greater Manchester Lead for Radiology
6.30 pm    Dr Alistair Craig, NWSOR

6.40 pm       Ian Young Memorial Lecture – “Nuclear Neuroradiology: the expanding role of Nuclear Medicine and PET CT in Neurology and Neurosurgery patients”  Dr John Cain, Consultant Neuroradiologist and Radionuclide Radiologist, Lancashire Teaching Hospitals NHS FT and Honorary Research Fellow, University of Manchester”

Synopsis:

This presentation will explore the current and potential future role of Nuclear Medicine and specifically PET CT in neuro degenerative disease diagnosis. There will be a discussion of the advantages and limitations of current methods including FGD PET, HMPAO SPECT , Amyloid imaging and Dopamine imaging and  introduce potential future tracers. There will be a discussion on current NICE guidance and potential future role of molecular imaging in the assessment of patients with cognitive impairment.  Which test is appropriate for different neurodegenerative diagnosis.

Dr Cain will discuss how recent advances in SPECT  CT has opened new avenues for evaluation of lumbar back pain with bone scans. SPECT CT bone scans can be used to identify MRI negative pain triggers in the spine and help plan treatment.

He will explore the current and potential future role of PET CT in neuro-oncology. There will be a  discussion of the limitations of MRI and problem of pseudo-progression vs true progression.  I will describe of the relative advantages and disadvantage of different tracers including the role of FDG and newer agents such as FLT, FET and F-DOPA.

7.30 pm    Registrar Presentations
CASE PRESENTATIONS – If you wish to present at this meeting please email your title and approx 4 lines about the topic to: Syahminan.Suut@srft.nhs.uk   Subject line to read: MMS Presentation

  • Closing date to be eligible for selection is the 26th October 2018. Successful applicants will be notified by the 2nd November.

8.00 pm    Buffet Supper